Terminology Service < Semantic Lookup Platform

All terms in GO

Label	Id	Description
negative regulation of protein homooligomerization	GO_0032463	[Any process that stops, prevents, or reduces the frequency, rate or extent of protein homooligomerization.]
positive regulation of protein homotetramerization	GO_1901095	[Any process that activates or increases the frequency, rate or extent of protein homotetramerization.]
positive regulation of protein homooligomerization	GO_0032464	[Any process that activates or increases the frequency, rate or extent of protein homooligomerization.]
regulation of autophagosome maturation	GO_1901096	[Any process that modulates the frequency, rate or extent of autophagosome maturation.]
negative regulation of autophagosome maturation	GO_1901097	[Any process that stops, prevents or reduces the frequency, rate or extent of autophagosome maturation.]
positive regulation of autophagosome maturation	GO_1901098	[Any process that activates or increases the frequency, rate or extent of autophagosome maturation.]
negative regulation of signal transduction in absence of ligand	GO_1901099	[Any process that stops, prevents or reduces the frequency, rate or extent of signal transduction in absence of ligand.]
obsolete hydrolase activity, acting on acid anhydrides, acting on GTP, involved in cellular and subcellular movement	GO_0050800	[OBSOLETE. Catalysis of the hydrolysis of GTP to directly drive the cellular or subcellular transport of a substance.]
regulation of synapse structure or activity	GO_0050803	[Any process that modulates the physical form or the activity of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).]
diazepam binding	GO_0050809	[Interacting selectively and non-covalently with diazepam, one of the most widely used benzodiazepine drugs. It is used as an anti-anxiety-hypnotic agent and has the proprietary name Valium.]
sleep	GO_0030431	[Any process in which an organism enters and maintains a periodic, readily reversible state of reduced awareness and metabolic activity. Usually accompanied by physical relaxation, the onset of sleep in humans and other mammals is marked by a change in the electrical activity of the brain.]
circadian sleep/wake cycle process	GO_0022410	[A behavioral process involved in the cycle from wakefulness through an orderly succession of sleep states and stages that occurs on an approximately 24 hour rhythm.]
GABA receptor binding	GO_0050811	[Interacting selectively and non-covalently with the gamma-aminobutyric acid (GABA, 4-aminobutyrate) receptor.]
epothilone metabolic process	GO_0050813	[The chemical reactions and pathways involving epothilone, a drug obtained from the myxobacteria Sporangium cellulosum that interferes with cell division. Some epothilones are being studied as treatments for cancer.]
epothilone biosynthetic process	GO_0050814	[The chemical reactions and pathways resulting in the formation of epothilone, a drug obtained from the myxobacteria Sporangium cellulosum that interferes with cell division. Some epothilones are being studied as treatments for cancer.]
phosphothreonine residue binding	GO_0050816	[Interacting selectively and non-covalently with a phosphorylated threonine residue within a protein.]
positive regulation of type IIa hypersensitivity	GO_0001798	[Any process that activates or increases the frequency, rate or extent of type IIa hypersensitivity, a type of inflammatory response.]
regulation of type IIa hypersensitivity	GO_0001796	[Any process that modulates the frequency, rate, or extent of type IIa hypersensitivity, a type of inflammatory response.]
positive regulation of type II hypersensitivity	GO_0002894	[Any process that activates or increases the frequency, rate, or extent of type II hypersensitivity.]
type IIa hypersensitivity	GO_0001794	[An inflammatory response resulting in cell death mediated by activation of the classical complement pathway or induction of effector cell phagocytosis or cytolysis mechanisms via complement or Fc receptors following the binding of antibodies to cell surface antigens on a target cell.]